Among sectors, pharma index is down more than 2 percent, while some buying is witnessing in metal and energy space.

Jan 18, 11:06 AM (IST)
Just IN | Shilpa Medicare has received US Food and Drug Administration approval for its ANDA, Imatinib Mesylate Tablets, 100 mg and 400 mg.

Jan 18, 10:48 AM (IST)
Rupee Update: The Indian rupee is trading flat at 71.07 per dollar versus previous close 71.05.

Jan 18, 10:38 AM (IST)
Rallis India slips post Q3 results: Shares of Rallis India fell 6 percent as investors reacted to the results for December quarter. The company’s net profit fell 45 percent, while operating profit declined by 27 percent.

Jan 18, 10:01 AM (IST)
Wipro Q3 preview: Constant currency revenue growth expected in 2-2.5% range

Jan 18, 09:46 AM (IST)
Sun Pharma plummets post whistleblower complaint: Shares of Sun Pharmaceuticals plummeted over 12 percent as investors reacted to a fresh complaint by a whistleblower against the company.

Jan 18, 09:29 AM (IST)
Buzzing: Shares of Cyient were down around 8 percent as investors turned wary of the stock after December quarter results’ announcement.

The company’s profit has fallen 27 percent to Rs 92.3 crore, while revenue remain unchanged at Rs 1,187.7 crore quarter on quarter. The company, which was supposed to consider buyback, will do so at a later date.

Jan 18, 09:18 AM (IST)
Market Opens: Benchmark indices started the day on the positive note with Nifty holding above 10,900 mark.

The Sensex is up 64.75 points at 36438.83, while Nifty is up 14.70 points at 10919.90. About 429 shares have advanced, 312 shares declined, and 30 shares are unchanged.

RIL, HUL, Vedanta, Hero Motocorp, Grasim, Hindalco, ONGC are the gainers, while Sun Pharma is down 11% and Lupin, Au Small Finance, Jet Airways, Interglobe Aviation are the other major losers.

source: moneycontrol.com